HomeProductsBioactive CompoundsPI3K/Akt/mTOR PathwayPI3KEganelisib
Chemical structure of CAS 1693758-51-8

Eganelisib

CAS No.1693758-51-8
MDL No.MFCD30533720
MFC30H24N8O2
MW528.60
InChI KeyXUMALORDVCFWKV-IBGZPJMESA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1693758-51-8
Product NameEganelisib

Biological Targets

PIK3CG

Associated Conditions

neoplasm
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Immunology • Vol. 160, Issue 1 • 2020
PMID: 32020584PMC: PMC7160657DOI: 10.1111/imm.13175

Discovery of 4-Methylquinazoline Based PI3K Inhibitors for the Potential Treatment of Idiopathic Pulmonary Fibrosis.

Journal of medicinal chemistry • Vol. 62, Issue 19 • 2019
PMID: 31335136DOI: 10.1021/acs.jmedchem.9b00969

Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical Candidate.

ACS medicinal chemistry letters • Vol. 7, Issue 9 • 2016
PMID: 27660692PMC: PMC5018865DOI: 10.1021/acsmedchemlett.6b00238

Documentation

Similar Products